Icahn School of Medicine at Mount Sinai Researcher Targets Chronic Myelomonocytic Leukemia (Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia)

Press/Media

Period18 Dec 2023

Media coverage

1

Media coverage

  • TitleIcahn School of Medicine at Mount Sinai Researcher Targets Chronic Myelomonocytic Leukemia (Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia)
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date18/12/23
    PersonsErin Moshier, Douglas Tremblay, John Mascarenhas, Alan Shih
View all 1
View less